E.U. Probes Boston Scientific, Abbott Over Guidant Bids
Also under review by the Commission is a portion of the acquisition deal involving Abbott Laboratories.
The Commission says it will hand down decisions on both aspects of the investigation by the end of the month.
Rather than treating the cases as simplified merger procedures, the Commission may decide to launch an in-depth investigation if the cases are found to raise competition...
To view the full article, register now.